ANL 29.80 Decreased By ▼ -1.55 (-4.94%)
ASC 20.40 Decreased By ▼ -0.50 (-2.39%)
ASL 23.60 Decreased By ▼ -0.30 (-1.26%)
BOP 8.26 Decreased By ▼ -0.15 (-1.78%)
BYCO 9.88 Decreased By ▼ -0.16 (-1.59%)
FCCL 21.85 Decreased By ▼ -0.35 (-1.58%)
FFBL 26.91 Decreased By ▼ -0.53 (-1.93%)
FFL 20.00 Decreased By ▼ -0.79 (-3.8%)
FNEL 8.74 Decreased By ▼ -0.11 (-1.24%)
GGGL 26.40 Decreased By ▼ -1.05 (-3.83%)
GGL 46.04 Decreased By ▼ -1.06 (-2.25%)
HUMNL 7.05 Decreased By ▼ -0.35 (-4.73%)
JSCL 21.62 Decreased By ▼ -0.88 (-3.91%)
KAPCO 38.70 Decreased By ▼ -1.10 (-2.76%)
KEL 3.90 Decreased By ▼ -0.02 (-0.51%)
MDTL 3.56 Decreased By ▼ -0.17 (-4.56%)
MLCF 43.50 Decreased By ▼ -0.77 (-1.74%)
NETSOL 158.50 Decreased By ▼ -7.45 (-4.49%)
PACE 7.45 Decreased By ▼ -0.22 (-2.87%)
PAEL 33.65 Decreased By ▼ -0.36 (-1.06%)
PIBTL 11.00 Decreased By ▼ -0.25 (-2.22%)
POWER 9.20 No Change ▼ 0.00 (0%)
PRL 23.00 Decreased By ▼ -0.80 (-3.36%)
PTC 11.60 Decreased By ▼ -0.13 (-1.11%)
SILK 1.83 Increased By ▲ 0.01 (0.55%)
SNGP 49.80 Increased By ▲ 0.20 (0.4%)
TELE 14.80 Decreased By ▼ -0.26 (-1.73%)
TRG 159.45 Decreased By ▼ -6.75 (-4.06%)
UNITY 40.45 Decreased By ▼ -2.52 (-5.86%)
WTL 3.59 Decreased By ▼ -0.15 (-4.01%)
BR100 5,096 Decreased By ▼ -70.59 (-1.37%)
BR30 25,755 Decreased By ▼ -734.03 (-2.77%)
KSE100 47,318 Decreased By ▼ -368.96 (-0.77%)
KSE30 18,974 Decreased By ▼ -155.31 (-0.81%)

Coronavirus
VERY HIGH Source: covid.gov.pk
Pakistan Deaths
23,133
4424hr
Pakistan Cases
1,015,827
4,11924hr
7.88% positivity
Sindh
371,762
Punjab
354,312
Balochistan
29,861
Islamabad
86,226
KPK
142,400
World

South Korea says to run mix-and-match trial of COVID-19 vaccines

  • A health official said the trial will include around 500 military personnel who were vaccinated with a first dose of AstraZeneca's COVID-19 shot.
  • The study will examine T cells - immune cells that can destroy virus-infected cells - and neutralising antibodies in those who were given a combination of doses, the health official told reporters.
20 May 2021

SEOUL: South Korea on Thursday said it will conduct a clinical trial that mixes COVID-19 vaccine doses developed by AstraZeneca Plc with those from Pfizer Inc and others.

The decision comes as a growing number of countries look into using different COVID-19 vaccines for first and second doses amid supply delays and safety concerns that have slowed their vaccination campaigns.

A health official said the trial will include around 500 military personnel who were vaccinated with a first dose of AstraZeneca's COVID-19 shot.

The study will examine T cells - immune cells that can destroy virus-infected cells - and neutralising antibodies in those who were given a combination of doses, the health official told reporters.

The timing and the size of the study has not been decided, the health official said, but will involve a diverse age group.

South Korea's vaccination campaign has been hampered by global shortages and shipment delays, deepening public scepticism over Seoul's goal of reaching herd immunity by November.

It has given first doses to just over 7% of its 52 million population, the Korea Disease Control and Prevention Agency (KDCA) data showed on Thursday.

KDCA reported 646 new confirmed cases of the coronavirus as of Wednesday midnight, bringing total infections to 134,117, with 1,916 deaths.